Issued Patents All Time
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10898567 | Synthetic long peptides (SLP) for therapeutic vaccination against Hepatitis B virus infection | Wilhelmus Johannes Theodorus Alexander Krebber, Johan Herman Kessler, Kitty Michelle Corinne Kwappenberg | 2021-01-26 |
| 10376576 | Synthetic long peptides (SLP) for therapeutic vaccination against hepatitis B virus infection | Wilhelmus Johannes Theodorus Alexander Krebber, Johan Herman Kessler, Kitty Michelle Corinne Kwappenberg | 2019-08-13 |
| 9522962 | Peptides, conjugates and method for increasing immunogenicity of a vaccine | Ferdinand Antonius Ossendorp, Jan Wouter Drijfhout | 2016-12-20 |
| 9393219 | Monophenols and benzenediols sensitization of immune system against haptenized melanoma antigens | Wiete Westerhof, Rosalie Luiten | 2016-07-19 |
| 7364741 | Peptides of human Papilloma virus for use in human T cell response inducing compositions | Wybe Martin Kast, Alessandro Sette, John Sidney | 2008-04-29 |
| 6682731 | Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 molecules | Alan Townsend, Judy Bastin, Thierry Boon-Falleur, Pierre van der Bruggen, Pierre Coulie +3 more | 2004-01-27 |
| 6147187 | Isolated tumor rejection antigen precursor mage-2 derived peptides and uses thereof | M. W. Visseren, W. Martin Kast, Pierre van der Bruggen, Thierry Boon-Falleur | 2000-11-14 |
| 6063900 | Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof | Marjan J. W. Visseren, W. Martin Kast, Pierre van der Bruggen, Thierry Boon-Falleur | 2000-05-16 |
| 5731160 | Induction of antigen specific T-lymphocyte responses by stimulation with peptide loaded MHC class I molecules on antigen processing defective mammalian cell lines | Wybe Martin Kast | 1998-03-24 |
| 5679641 | Peptides of human P53 protein for use in human T cell response inducing compositions, and human P53 protein-specific cytotoxic t-lymphocytes | Wybe Martin Kast | 1997-10-21 |
| 5554724 | Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof | M. J. W. Visseren, W. Martin Kast, Pierre van der Bruggen, Thierry Boon-Falleur | 1996-09-10 |